US 11453721
Bispecific anti-MUC16 x anti-CD28 antibodies and uses thereof
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 11453721 (Bispecific anti-MUC16 x anti-CD28 antibodies and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Sep 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K39/3955, A61P